A2A Pharmaceuticals

ECM Deals

DateCompanyTransaction TypeTotal Value
01/02/18A2A PharmaceuticalsPlacement$4.4m>>


A2A Pharmaceuticals Inc. is a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents. Its focus is on the development of novel drugs to treat antibiotic-resistant bacterial infections, tuberculosis and address unmet needs in cancer.
Biography last updated 10 Apr 2018

BNiQ Disclaimer